IHoMe-PCC: Pharmaceutical Care from a Systems Perspective in Case Study of Schizophrenia Patients

Main Article Content

Charkkrit Hongthong
Juthamanee Dudsadeeprasert
Nusaraporn Kessomboon

Abstract

Introduction: Schizophrenia treatment with antipsychotic drug can reduce the chance of illness recurrence. However, the prevalence of non-adherence to antipsychotic medication in schizophrenia was 41% which increased the risk of self-harm, community violence, and rehospitalization. The most common cause of noncooperation in treatment and medication non-adherence. Materials and Method: Integrated Hospital Medication Management System for Psychiatric Pharmaceutical Care (IHoMe-PCC) was developed by focusing on patient-centered approach using the Integrated Hospital Medication Management System 2017 (IHoMe 2017), pharmacist shared decision making services, gap analysis, and sharing patient information to health team and community care team. Result and conclusion: The 2 case studies revealed that IHoMe-PCC can improve patient medication adherence, no rehospitalization within 90 days, and earning the highest patient satisfaction rating.

Article Details

Section
Pharmaceutical Practice

References

A. for H.R. and Q.(AHRQ), 2014. The SHARE Approach Essential Steps of Shared Decision Making. September 2016, (14).

Aljumah, K. and Hassali, M.A., 2015. Impact of pharmacist intervention on adherence and measurable patient outcomes among depressed patients: a randomised controlled study. BMC Psychiatry, 1–9.

Anderson, K. et al., 2015. Polypharmacy, deprescribing and shared decision-making in primary care: The role of the accredited pharmacist. Journal of Pharmacy Practice and Research, 45(4), 446–449.

Blagburn, J. and Simpson, S., 2014. Pharmacy professionals use shared decision making approaches to help patients better understand their medicines. The Health Foundation, (January).

Chakri Kaeokumbong and Aporanee Chaiyakum, 2015. Effectiveness of Pharmaceutical Care at Schizophrenia Clinic in Psychiatric Hospital. IJPS, March 2015; 11(Supplement) : 159-167.

Elwyn, G. et al., 2012. Shared decision making: A model for clinical practice. Journal of General Internal Medicine, 27(10), 1361–1367.

Haddad, P.M., Brain, C. & Scott, J., 2014. Nonadherence With Antipsychotic Medication. Dovepress, 43–62.

Hamann, J. et al., 2006. Shared decision making for in-patients with schizophrenia. Acta Psychiatrica Scandinavica, 114(4), 265–273.

IHoMe Network:, Faculty of Pharmceutical Sciences Khon Kaen University and Udonthani Hospital, 2017. Integrated Hospital Medication Management System, IHoMe.

Kanjanasilp, J. and Ploylearmsang, C., 2016. A short term outcomes of pharmaceutical care in Thai patients with schizophrenia : a randomized controlled trial. Songklanakarin J. Sci. Technol., 38(2), 189–197.

Manote Lortrakul and Pramote Sukanich, 2012. Ramathibodi Essential Psychiatry Fourth Edition, Bangkok : Department of Psychiatry, Faculty of Medicine Ramathibodi Hospital.

Rational Use of Drug Subcommittee, 2017. Teacher’s Guide for Promoting Rational Drug Use. Nonthaburi: Food and Drug Administration, Ministry of Public Health, Thailand.

Rossamalin Chabunthom, 2007. Effect of depression on medication adherance and glycemic control in patients with type 2 diabetes.

Schafer, K.M., Gionfriddo, M.R. & Boehm, D.H., 2016. Shared decision making and medication therapy management with the use of an interactive template. Journal of the American Pharmacists Association, 56(2), 166–172.

Sirijit Suttajit and Manit Srisurapanont, 2009. Schizophrenia : Epidemiology and Treatment. J Psychiatr Assoc Thailand 2009; 54(Supplement): 21-37.

Tareke, M. et al., 2018. Antipsychotic medication non-adherence among schizophrenia patients in Central Ethiopia. South African Journal of Psychiatry, 24(1), 1–6.

Younas, M. et al., 2016. Mental health pharmacists views on shared decision-making for antipsychotics in serious mental illness. International Journal of Clinical Pharmacy, 38(5), 1191–1199.